Saratoga, CA, United States of America

Rosy Sheng Donn

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Allergan, Inc., Dade Behring Inc.. Active years: 2000-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosy Sheng Donn. Retrieved from https://idiyas.com/inventor/rosy-sheng-donn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7


 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 2000-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Rosy Sheng Donn

Introduction:

Rosy Sheng Donn, based in Saratoga, California, is a prominent inventor recognized for her groundbreaking work in the field of ocular implants. With a remarkable portfolio of nine patents, she has made significant strides in healthcare innovations, particularly in treating ocular conditions. Her latest patent showcases her commitment and creativity in advancing medical treatments.

Latest Patents:

One of Rosy Sheng Donn's notable recent innovations is the patent titled "Sustained Release Intraocular Implants and Methods for Treating Ocular Vasculopathies." This invention focuses on biocompatible intraocular implants that incorporate an alpha-2 adrenergic receptor agonist along with a polymer to enable the prolonged release of this agonist into the eye. The innovative use of a biodegradable polymer matrix enhances the effectiveness of the implant in treating various ocular issues, such as ocular vasculopathy and glaucoma. This patent exemplifies Donn's dedication to improving patient outcomes through advanced medical technologies.

Career Highlights:

Donn has built a successful career within esteemed organizations, including Allergan, Inc. and Dade Behring Inc. Her experience in these companies has equipped her with the skills and insights necessary to innovate in the field of eye care. Her hard work and dedication to research and development have positioned her as a leading figure in ocular health technology.

Collaborations:

Throughout her career, Rosy has collaborated with other notable scientists and professionals, including Glenn T. Huang and James A. Burke. These collaborations have greatly contributed to her innovative projects and the overall advancements in medical treatments, further solidifying her reputation as an influential inventor.

Conclusion:

In summary, Rosy Sheng Donn stands out as a leading inventor in the realm of ocular health, with patents that reflect her dedication and innovative mindset. Her recent work in intraocular implants not only showcases her technical prowess but also highlights her commitment to improving the quality of life for individuals suffering from ocular conditions. As she continues to push the boundaries of innovation, her contributions to the medical field will undoubtedly have a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…